Working... Menu

Addition of Enzalutamide to First Line Docetaxel for Castration Resistant Prostate Cancer (CHEIRON)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02453009
Recruitment Status : Unknown
Verified May 2015 by Orazio Caffo, Santa Chiara Hospital.
Recruitment status was:  Recruiting
First Posted : May 25, 2015
Last Update Posted : May 25, 2015
Information provided by (Responsible Party):
Orazio Caffo, Santa Chiara Hospital

No Study Results Posted on for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : September 2016
  Estimated Study Completion Date : December 2016